Identification of Treatment Concentrations of Defactinib or VS-6766 for the Treatment of Patients With Glioblastoma
Clinical trial NCT05798507 · ACTIVE_NOT_RECRUITING
Trial details
- NCT number
- NCT05798507
- Sponsor
- Emory University
- Status
- ACTIVE_NOT_RECRUITING
- Phase
- Early Phase 1
- Study type
- INTERVENTIONAL
- Start date
- 2023-07-28
- Primary completion
- 2026-12-03
- Enrollment
- 14
Track trials programmatically
Sponsors, conditions and status changes through the Atlas API.